FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:LSM14A-LYN

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: LSM14A-LYN
FusionPDB ID: 50191
FusionGDB2.0 ID: 50191
HgeneTgene
Gene symbol

LSM14A

LYN

Gene ID

26065

4067

Gene nameLSM14A mRNA processing body assembly factorLYN proto-oncogene, Src family tyrosine kinase
SynonymsC19orf13|FAM61A|RAP55|RAP55AJTK8|p53Lyn|p56Lyn
Cytomap

19q13.11

8q12.1

Type of geneprotein-codingprotein-coding
Descriptionprotein LSM14 homolog ALSM14 homolog ALSM14A, SCD6 homolog ARNA-associated protein 55RNA-associated protein 55AalphaSNBPfamily with sequence similarity 61, member AhRAP55hRAP55Aprotein SCD6 homologputative alpha-synuclein-binding proteintyrosine-protein kinase Lynlck/Yes-related novel protein tyrosine kinasev-yes-1 Yamaguchi sarcoma viral related oncogene homolog
Modification date2020032720200327
UniProtAcc

Q8ND56

Main function of 5'-partner protein: FUNCTION: Essential for formation of P-bodies, cytoplasmic structures that provide storage sites for translationally inactive mRNAs and protect them from degradation (PubMed:16484376, PubMed:17074753, PubMed:29510985). Acts as a repressor of mRNA translation (PubMed:29510985). May play a role in mitotic spindle assembly (PubMed:26339800). {ECO:0000269|PubMed:16484376, ECO:0000269|PubMed:17074753, ECO:0000269|PubMed:26339800, ECO:0000269|PubMed:29510985}.

P0DP58

Main function of 5'-partner protein: FUNCTION: Acts in different tissues through interaction to nicotinic acetylcholine receptors (nAChRs) (PubMed:21252236). The proposed role as modulator of nAChR activity seems to be dependent on the nAChR subtype and stoichiometry, and to involve an effect on nAChR trafficking and its cell surface expression, and on single channel properties of the nAChR inserted in the plasma membrane. Modulates functional properties of nicotinic acetylcholine receptors (nAChRs) to prevent excessive excitation, and hence neurodegeneration. Enhances desensitization by increasing both the rate and extent of desensitization of alpha-4:beta-2-containing nAChRs and slowing recovery from desensitization. Promotes large amplitude ACh-evoked currents through alpha-4:beta-2 nAChRs. Is involved in regulation of the nAChR pentameric assembly in the endoplasmic reticulum. Shifts stoichiometry from high sensitivity alpha-4(2):beta-2(3) to low sensitivity alpha-4(3):beta-2(2) nAChR (By similarity). In vitro modulates alpha-3:beta-4-containing nAChRs. Reduces cell surface expression of (alpha-3:beta-4)(2):beta-4 and (alpha-3:beta-4)(2):alpha-5 nAChRs suggesting an interaction with nAChR alpha-3(-):(+)beta-4 subunit interfaces and an allosteric mode. Corresponding single channel effects characterized by decreased unitary conductance, altered burst proportions and enhanced desensitization/inactivation seem to depend on nAChR alpha:alpha subunit interfaces and are greater in (alpha-3:beta-2)(2):alpha-3 when compared to (alpha-3:beta-2)(2):alpha-5 nAChRs (PubMed:28100642). Prevents plasticity in the primary visual cortex late in life (By similarity). {ECO:0000250|UniProtKB:P0DP60, ECO:0000269|PubMed:21252236, ECO:0000269|PubMed:28100642}.
Ensembl transtripts involved in fusion geneENST idsENST00000433627, ENST00000540746, 
ENST00000544216, 
ENST00000420292, 
ENST00000519728, ENST00000520220, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score18 X 10 X 10=180013 X 14 X 7=1274
# samples 2415
** MAII scorelog2(24/1800*10)=-2.90689059560852
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(15/1274*10)=-3.08633087176042
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: LSM14A [Title/Abstract] AND LYN [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: LSM14A [Title/Abstract] AND LYN [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)LSM14A(34706566)-LYN(56879274), # samples:1
Anticipated loss of major functional domain due to fusion event.LSM14A-LYN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LSM14A-LYN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LSM14A-LYN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
LSM14A-LYN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneLSM14A

GO:0033962

cytoplasmic mRNA processing body assembly

16484376

TgeneLYN

GO:0006468

protein phosphorylation

11517336

TgeneLYN

GO:0006974

cellular response to DNA damage stimulus

10891478|11517336

TgeneLYN

GO:0018108

peptidyl-tyrosine phosphorylation

7682714|11782428

TgeneLYN

GO:0046777

protein autophosphorylation

7682714

TgeneLYN

GO:0051272

positive regulation of cellular component movement

16467205

TgeneLYN

GO:0070304

positive regulation of stress-activated protein kinase signaling cascade

10891478



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:34706566/chr8:56879274)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across LSM14A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across LYN (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000540746LSM14Achr1934706566+ENST00000519728LYNchr856879274+1987776851524479
ENST00000540746LSM14Achr1934706566+ENST00000520220LYNchr856879274+2796776851524479
ENST00000544216LSM14Achr1934706566+ENST00000519728LYNchr856879274+2069858441606520
ENST00000544216LSM14Achr1934706566+ENST00000520220LYNchr856879274+2878858441606520
ENST00000433627LSM14Achr1934706566+ENST00000519728LYNchr856879274+2067856421604520
ENST00000433627LSM14Achr1934706566+ENST00000520220LYNchr856879274+2876856421604520

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000540746ENST00000519728LSM14Achr1934706566+LYNchr856879274+0.0064943710.9935056
ENST00000540746ENST00000520220LSM14Achr1934706566+LYNchr856879274+0.0031600030.99684
ENST00000544216ENST00000519728LSM14Achr1934706566+LYNchr856879274+0.0049743530.9950257
ENST00000544216ENST00000520220LSM14Achr1934706566+LYNchr856879274+0.0024533570.9975466
ENST00000433627ENST00000519728LSM14Achr1934706566+LYNchr856879274+0.0049774450.99502254
ENST00000433627ENST00000520220LSM14Achr1934706566+LYNchr856879274+0.0024408150.9975592

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for LSM14A-LYN

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
LSM14Achr1934706566LYNchr856879274776230ENEQLRNDNKRQVGYYNNSTKVAVKT
LSM14Achr1934706566LYNchr856879274856271ENEQLRNDNKRQVGYYNNSTKVAVKT
LSM14Achr1934706566LYNchr856879274858271ENEQLRNDNKRQVGYYNNSTKVAVKT

Top

Potential FusionNeoAntigen Information of LSM14A-LYN in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LSM14A-LYN_34706566_56879274.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LSM14A-LYNchr1934706566chr856879274856HLA-C07:46LRNDNKRQVGY0.98590.8882415

Top

Potential FusionNeoAntigen Information of LSM14A-LYN in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LSM14A-LYN_34706566_56879274.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LSM14A-LYNchr1934706566chr856879274856DRB1-0301NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0301ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0301EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0303NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0303ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0303EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0305NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0305ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0305EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0307NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0307ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0307EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0310NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0310ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0310EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0313NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0313ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0313EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0315NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0315ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0315EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0318NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0318ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0318EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0320NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0320ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0320EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0322NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0322ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0322EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0324NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0324ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0324EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0326NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0326ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0326EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0328NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0328ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0328EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0330NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0330ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0330EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0332NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0332ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0332EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0334NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0334ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0334EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0336NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0336ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0336EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0338NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0338ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0340NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0340ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0340EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0342NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0342ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0344NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0344ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0344EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0346NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0346ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0346EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0348NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0348ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0348EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0350NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0350ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0350EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0352NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0352ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0352EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0354NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-0354ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-0354EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-0434QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1107NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1107ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1107EQLRNDNKRQVGYYN217
LSM14A-LYNchr1934706566chr856879274856DRB1-1130QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1153QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1153NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1168NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1179NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1179ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1182NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1329NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1331NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1331ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1333NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1333ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1336NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1336ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1337NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1341NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1341ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1343NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1343ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1367QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1367RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1371NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1371ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1376NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1381NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1381ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1394NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1394ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1396NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1396ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1407QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1407RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1414QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1414RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1416NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1416ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1419NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1419ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1421NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1421ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1436QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1436RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1437NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1437ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1438NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1438ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1442QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1442RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1444QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1444RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1451QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1451RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1468QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1468RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1476NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1476ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1479NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1479ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1482ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB1-1482NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1493QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB1-1493RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB1-1495NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB1-1495ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB3-0114NEQLRNDNKRQVGYY116
LSM14A-LYNchr1934706566chr856879274856DRB3-0114ENEQLRNDNKRQVGY015
LSM14A-LYNchr1934706566chr856879274856DRB3-0202QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0202RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0202KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0205QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0205RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0205KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0209QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0209RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0210QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0210RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0210KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0211QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0211RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0211KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0212QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0212RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0212KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0213QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0213RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0214QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0215QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0215RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0215KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0216RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0216QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0217QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0217RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0217KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0218QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0218RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0218KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0219QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0219RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0220QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0220RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0220KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0221QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0221RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0222QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0222RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0223QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0223RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0223KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0225QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB3-0225RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0225KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB3-0303RQVGYYNNSTKVAVK1025
LSM14A-LYNchr1934706566chr856879274856DRB3-0303QVGYYNNSTKVAVKT1126
LSM14A-LYNchr1934706566chr856879274856DRB5-0202KRQVGYYNNSTKVAV924
LSM14A-LYNchr1934706566chr856879274856DRB5-0202NKRQVGYYNNSTKVA823

Top

Fusion breakpoint peptide structures of LSM14A-LYN

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6119NDNKRQVGYYNNSTLSM14ALYNchr1934706566chr856879274856

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of LSM14A-LYN

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6119NDNKRQVGYYNNST-7.15543-7.26883
HLA-B14:023BVN6119NDNKRQVGYYNNST-4.77435-5.80965
HLA-B52:013W396119NDNKRQVGYYNNST-6.80875-6.92215
HLA-B52:013W396119NDNKRQVGYYNNST-4.20386-5.23916
HLA-A11:014UQ26119NDNKRQVGYYNNST-7.5194-8.5547
HLA-A11:014UQ26119NDNKRQVGYYNNST-6.9601-7.0735
HLA-A24:025HGA6119NDNKRQVGYYNNST-7.52403-7.63743
HLA-A24:025HGA6119NDNKRQVGYYNNST-5.82433-6.85963
HLA-B27:056PYJ6119NDNKRQVGYYNNST-3.28285-4.31815
HLA-B44:053DX86119NDNKRQVGYYNNST-5.91172-6.94702
HLA-B44:053DX86119NDNKRQVGYYNNST-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of LSM14A-LYN

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
LSM14A-LYNchr1934706566chr856879274415LRNDNKRQVGYTCAGAAATGATAACAAGAGACAAGTAGGTTACT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
LSM14A-LYNchr1934706566chr856879274015ENEQLRNDNKRQVGYAAAATGAGCAACTCAGAAATGATAACAAGAGACAAGTAGGTTACT
LSM14A-LYNchr1934706566chr856879274116NEQLRNDNKRQVGYYATGAGCAACTCAGAAATGATAACAAGAGACAAGTAGGTTACTATA
LSM14A-LYNchr1934706566chr8568792741025RQVGYYNNSTKVAVKGACAAGTAGGTTACTATAACAACAGTACCAAGGTGGCTGTGAAAA
LSM14A-LYNchr1934706566chr8568792741126QVGYYNNSTKVAVKTAAGTAGGTTACTATAACAACAGTACCAAGGTGGCTGTGAAAACCC
LSM14A-LYNchr1934706566chr856879274217EQLRNDNKRQVGYYNAGCAACTCAGAAATGATAACAAGAGACAAGTAGGTTACTATAACA
LSM14A-LYNchr1934706566chr856879274823NKRQVGYYNNSTKVAACAAGAGACAAGTAGGTTACTATAACAACAGTACCAAGGTGGCTG
LSM14A-LYNchr1934706566chr856879274924KRQVGYYNNSTKVAVAGAGACAAGTAGGTTACTATAACAACAGTACCAAGGTGGCTGTGA

Top

Information of the samples that have these potential fusion neoantigens of LSM14A-LYN

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADLSM14A-LYNchr1934706566ENST00000433627chr856879274ENST00000519728TCGA-HU-A4GN-01A

Top

Potential target of CAR-T therapy development for LSM14A-LYN

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to LSM14A-LYN

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to LSM14A-LYN

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource